E.e.s Granule, For Suspension
NDC Package 80005-152-18

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

E.e.s (erythromycin ethylsuccinate) granules is erythromycin is used to treat a wide variety of bacterial infections. This formulation utilizes a granule, for suspension delivery system. Marketed by Carnegie Pharmaceuticals Llc, this product is identified by NDC 80005-152 and is authorized under FDA application NDA050207.

Identification & Billing

NDC Package Code
80005-152-18
Package Description
100 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
80005015218
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
100 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
E.e.s
Non-Proprietary Name
Erythromycin Ethylsuccinate
Substance Name
Erythromycin Ethylsuccinate
Dosage Form
Granule, For Suspension - A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Erythromycin is used to treat a wide variety of bacterial infections. It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Carnegie Pharmaceuticals Llc
Product Type
Human Prescription Drug
FDA Application #
NDA050207
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-15-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 80005-152-18 identifies a specific commercial package of 100 ml in 1 bottle of E.e.s, a human prescription drug labeled by Carnegie Pharmaceuticals Llc. This granule, for suspension is formulated for oral use and contains erythromycin ethylsuccinate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Carnegie Pharmaceuticals Llc on January 15, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Erythromycin is used to treat a wide variety of bacterial infections. It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Carnegie Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 80005015218. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
80005-152-18
11-Digit CMS (5-4-2)
80005-0152-18

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.